Introduction {#s1}
============

The maturation of all nuclear-encoded mRNAs in trypanosomes requires trans-splicing. Polycistronic pre-mRNA is co-transcriptionally processed to monocistronic mRNAs by two coupled steps that trans-splice a 39-nucleotide leader from the spliced leader RNA (SL RNA) to the 5′ end of the mRNA, and then cleave and polyadenylate the 3′ end of the upstream mRNA ([@b8]; [@b47]; [@b101]; [@b60]). The SL RNA is transcribed by RNA polymerase II ([@b23]) and is capped ([@b55]); trans-splicing provides a mechanism to add a 5′ cap to the mature mRNA. Cis-splicing is very rare and occurs in only two genes ([@b55]; [@b33]; [@b42]; [@b85]). The mechanism of trans-splicing is analogous to the cis-splicing reaction ([@b68]; [@b91]). The spliceosomes that catalyse cis- and trans-splicing are similar: five snRNAs each associate with seven core Sm proteins in ring-shaped structures -- SmB, SmD1, SmD2, SmD3, SmE, SmF and SmG for U1, U2, U4 and U5 snRNPs, and Lsm2--Lsm8 for U6. In trans-splicing, the SL RNA replaces the U1 snRNA in the spliceosome ([@b96]; [@b103]; [@b26]; [@b71]).

Inhibition of trans-splicing in trypanosomes by heat shock results in the accumulation of incompletely processed mRNAs that are capped and polyadenylated but contain two or more open reading frames in tandem ([@b66]; [@b67]). A convenient assay for incompletely processed mRNAs takes advantage of the structure of the tubulin locus which contains 19 tandem repeats of α- and β-tubulin genes (..αβαβα..) ([@b81]; [@b97]; [@b19]); trans-splicing of β-tubulin is more efficient than of α-tubulin ([@b66]; [@b67]; [@b84]) and upon inhibition of trans-splicing, there is an accumulation of β-α dicistronic RNA, β-α-β-α tetracistronic RNA, and so on, with a lesser accumulation of odd number cistronic RNAs. Low levels of dicistronic tubulin RNA can be detected in cells under normal growth conditions ([@b66]) and the accumulation of oligocistronic RNAs on heat shock thus probably represents an increase in a pre-existing pool rather than the appearance of novel RNAs. The incompletely processed tubulin mRNAs induced by heat shock are not processed into mature mRNAs during recovery from heat shock ([@b66]), but little is known of their fate and whether they are retained in the nucleus or exported to the cytoplasm.

After export to the cytoplasm, there is spatial regulation of mRNA metabolism with aggregation of mRNA and associated proteins into granules. Cytoplasmic mRNP granules are thought to regulate mRNA turn-over and translation by regulating access to translation, storage and decay pathways, including nonsense-mediated decay and microRNA-induced gene silencing ([@b2]). P-bodies are a subset of these mRNP granules and contain enzymes involved in 5′ to 3′ decay: the decapping complex Dcp1--Dcp2 and the 5′ to 3′ exoribonuclease Xrn1, as well as proteins with a function in translational repression, such as Scd6 and the RNA helicase Dhh1. The behaviour of P-body proteins is consistent with an equilibrium existing between P-bodies and polysomes; cycloheximide prevents polysome disassembly and diminishes P-bodies, whereas puromycin causes polysome disassembly and increases P-bodies ([@b82]; [@b38]; [@b1]). mRNAs also move between P-bodies and polysomes ([@b7]; [@b5]). Although the components and dynamic behaviour of P-bodies have been characterised, the exact functions remain unclear.

Other mRNP granules are restricted to particular developmental stages or appear in response to stress. Germ granules, such as P-granules in *Caenorhabditis elegans* and polar granules in *Drosophila melanogaster*, store a subset of maternal mRNAs in developing embryos. In *C. elegans*, germ granules are cytoplasmic in the early embryo, but become perinuclear in germ line cells of later stages ([@b18]; [@b53]; [@b54]; [@b88]; [@b89]; [@b28]). Such perinuclear germ granules are associated with nuclear pores, and this location suggests a possible function in the regulation of export and/or quality control and/or determination of fate ([@b72]; [@b83]). Germ granules interact with P-bodies and share some components, but are a distinct type of mRNP granule ([@b21]); prominent germ granule proteins are Pgl-1 in *C. elegans* and the RNA helicase Vasa in *Drosophila* (Glh-1 in *C. elegans*) ([@b87]).

mRNP granules have been described in trypanosomes, and include starvation stress granules ([@b9]), heat shock stress granules ([@b43]) and P-bodies ([@b9]; [@b31]; [@b43]). P-bodies are constitutively present and contain DHH1, SCD6 and XRNA, the Xrn1 homologue ([@b9]; [@b31]; [@b43]), but the decapping reaction probably differs from yeast and mammals because the enzyme, Dcp1--Dcp2 and the regulators of decapping, Lsm1 and Pat1, are not apparent in the genome, although decapping activity has been identified ([@b63]).

Here, it is shown that the inhibition of trans*-*splicing and consequent accumulation of incompletely processed mRNA causes the redistribution of a set of proteins involved in mRNA metabolism in the cytoplasm to granules close to the periphery of the nucleus. The proteins included all P-body components characterised to date in trypanosomes and additionally poly(A) binding protein 2 and the homologue of Vasa. Proteins involved in mRNA maturation and export from the nucleus did not localise to the granules. The nuclear periphery granules differ from P-bodies because their presence is dependent on active transcription, and they are unaffected by cycloheximide. The inclusion of Vasa in particular suggests a similarity to perinuclear germ granules, and it is possible that the trypanosome nuclear periphery granules fulfil a similar function in sorting and/or quality control of newly transcribed mRNAs.

Results {#s2}
=======

Inhibition of trans-splicing causes P-body proteins to relocalise to granules at the nuclear periphery {#s2a}
------------------------------------------------------------------------------------------------------

Trans-splicing can be inhibited by a range of methods: degradation of U2, U4 or U6 snRNAs by the addition of complementary oligonucleotides and RNAse H to permeabilised cells ([@b98]), inhibition of methylation of the SL RNA using sinefungin, an S-adenosylmethionine analogue ([@b62]), and by RNAi depletion of the spliceosome components SmE and SmD ([@b56]). Sinefungin was chosen for the initial experiments because it does not require permeabilised cells, and accumulation of partially processed mRNAs occurs within a few minutes. By contrast, the onset of phenotype after RNAi depletion of spliceosome components takes more than 24 hours. The addition of sinefungin has immediate and downstream effects. For mRNA, the immediate effect is to inhibit methylation of SL RNA, the consequence is an inhibition of trans-splicing, which, in turn, has the effect of decreasing the cytoplasmic mRNA pool through turn-over because the mean half-life, measured after inhibition of transcription and trans-splicing, is less than 30 minutes ([@b57]).

The starting procyclic trypanosome cell line expressed eYFP--DHH1 and SCD6--mChFP from modified endogenous loci and has been described previously ([@b39]; [@b43]). In untreated cells, both proteins are cytoplasmic, with an average of around three microscopically visible P-bodies ([@b43]) ([Fig. 1A](#f01){ref-type="fig"}). Upon addition of sinefungin, a fraction of each protein relocalised to \>10 granules distributed around the nucleus within 15 minutes: these were named nuclear periphery granules (NPGs). The remainder of each protein continued to be localised in the cytoplasm and was concentrated in P-bodies distant from the nucleus. This distribution altered with time: 60 minutes after sinefungin addition, P-bodies had increased in size and were more prominent than the NPGs ([Fig. 1A](#f01){ref-type="fig"}). The increase in number and size of P-bodies coincided with a decrease in polysomes ([Fig. 1A](#f01){ref-type="fig"}).

![**Nuclear periphery granules.** (**A,B**) Time course of the effect of (A) sinefungin or (B) actinomycin D on cells expressing eYFP--DHH1 and SCD6--mChFP. Images of typical cells and polysome profiles are shown, arrows indicate NPGs. (**C**,**D**) Inhibition of splicing using a morpholino oligo antisense to part of U2 snRNA in a cell line expressing eYFP--DHH1. (C) Cells were imaged 2 hours after electroporation, arrows indicate NPGs. (D) Northern blot analysis of incompletely processed tubulin mRNAs in untreated cells, cells treated with sinefungin for 30 minutes and cells harvested 2 hours after electroporation of the morpholino.](jcs-125-12-2896-f01){#f01}

The event(s) necessary for relocation of eYFP--DHH1 and SCD6--mChFP to NPGs were investigated. Transcription was inhibited by actinomycin D; there was no formation of NPGs, whereas P-bodies increased in size, and polysomes decreased, indicating that NPGs do not form as a response to the absence of newly synthesised mRNAs or to the decrease in polysomes ([Fig. 1B](#f01){ref-type="fig"}). To determine whether the formation of NPGs was caused by the inhibition of trans-splicing or some other effect of sinefungin, a morpholino oligo designed to base pair with bases 27--51 of the U2 snRNA was introduced into the cells by electroporation ([@b99]). The same approach has been used to inhibit cis-splicing in metazoa ([@b59]). Electroporation of the U2 morpholino, but not a control oligo, caused eYFP--DHH1 to localise to NPGs ([Fig. 1C](#f01){ref-type="fig"}). To confirm that the morpholino inhibited splicing, RNA from electroporated cells was analysed for the presence of partially processed tubulin mRNAs. Cells electroporated with the U2 snRNA antisense morpholino contained tubulin dicistrons at approximately the same level as cells treated with sinefungin for 30 minutes ([Fig. 1D](#f01){ref-type="fig"}). These data indicate that NPGs form as a consequence of the inhibition of trans-splicing and not from the absence of another methylation reaction inhibited by sinefungin.

A titration of sinefungin was performed to determine the minimum concentration required for nuclear periphery granule formation and the accumulation of incompletely processed tubulin mRNAs. Sinefungin was titrated from 5.2 µM (2 µg/ml) used in the experiments above, to 5.2 nM. Both NPG formation and the appearance of incompletely processed tubulin mRNAs had a similar threshold concentration of sinefungin, between 5.2 and 52 nM ([supplementary material Fig. S1A,B](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). With increasing sinefungin concentration, the relative amounts of dicistronic tubulin mRNAs decreased and tetracistronic and polycistronic RNAs increased, reflecting a greater inhibition of trans-splicing ([supplementary material Fig. S1B](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). The effect of sinefungin on nuclear periphery granule formation could be blocked by co-incubation with excess S-adenosyl methionine, as expected ([supplementary material Fig. S1C](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)).

A third method to inhibit trans-splicing is RNAi depletion of the Sm core protein SmE ([@b56]). When this RNAi experiment was repeated in a cell line carrying an eYFP--DHH1 transgene, growth arrest occurred after roughly two population doubling times, but there was a reduced accumulation of incompletely processed tubulin mRNA compared with results obtained in the presence of sinefungin, possibly because of incomplete inhibition of trans-splicing ([supplementary material Fig. S2](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). However, eYFP--DHH1 did not localise to NPGs, suggesting that almost complete inhibition of trans-splicing is necessary for NPG formation, a model reinforced by the observation that NPGs can form in the majority of SmE-depleted cells upon addition of sinefungin ([supplementary material Fig. S2C](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). Taken together, the data provide strong evidence that NPGs form as a consequence of an accumulation of incompletely processed mRNAs above a threshold concentration.

NPGs are located outside the nuclear membrane and do not form if nuclear integrity is compromised by knockdown of NUP158 {#s2b}
------------------------------------------------------------------------------------------------------------------------

The subcellular localisation of the NPGs was characterised in more detail. A cell line expressing three times wild-type levels of SCD6--eYFP was treated with sinefungin and individual nuclei were imaged at high resolution. In serial optical sections, the granules are relatively uniform in size and are evenly distributed around the nucleus ([Fig. 2A](#f02){ref-type="fig"}). To determine whether the NPGs were localised inside or outside the nuclear membrane, the nuclear periphery was visualised by expressing NUP96--eYFP in a cell line expressing mChFP--DHH1. *Trypanosoma brucei* NUP96 (Tb927.10.7060) was identified in the proteome of *T. brucei* nuclear pores and localises to a series of discrete spots at the nuclear periphery that probably coincide with nuclear pores ([@b14]). NUP96--eYFP localised to small spots at the rim of the nucleus, and its localisation was unaffected by sinefungin ([Fig. 2B](#f02){ref-type="fig"}). The NPGs containing mChFP--DHH1 were localised outside the NUP96--eYFP spots ([Fig. 2B,C](#f02){ref-type="fig"}), suggesting that the granules formed in the cytoplasm and not in the nucleus. NPG stability after addition of 0.5% n-octylglucoside was determined, this concentration dissolves the plasma membrane but not the nuclear membrane. Upon addition of n-octylglucoside, the localisation of NUP96--eYFP was unaffected, whereas NPGs disappeared, providing further evidence that the NPGs are cytoplasmic ([Fig. 2B](#f02){ref-type="fig"}).

![**NPGs are localised outside the nucleus and require nuclear integrity.** (**A**) Deconvolved optical sections (0.24 µm intervals) of a typical cell expressing SCD6--eYFP after incubation for 120 minutes with sinefungin. (**B**) Stability of NPGs after detergent lysis of the plasma membrane of cells expressing NUP96--eYFP and mChFP--DHH1. Cells were not lysed (top), treated with sinefungin (middle) or treated with sinefungin followed by detergent lysis (bottom). (**C**) Localisation of NUP96--eYFP and mChFP--DHH1 after incubation with sinefungin for 60 minutes. A single optical section from a deconvolved *Z*-stack is shown. (**D**--**F)** Tetracycline-inducible RNAi depletion of NUP158 in cells expressing mChFP--DHH1 and NUP62--eYFP. (D) Northern blot probed for *NUP158*. (E) Growth after induction of NUP158 RNAi. (F) Images of cells after incubation with sinefungin for 60 minutes.](jcs-125-12-2896-f02){#f02}

To test whether the formation of the NPGs was dependent on nuclear integrity, the nucleoporin NUP158 (Tb11.03.0140) ([@b14]) was knocked down using tetracycline inducible RNAi in a cell line expressing both mChFP--DHH1 and NUP62--eYFP (Tb927.4.5200) as a marker of nuclear pores ([@b14]). Both transgenes were expressed from modified endogenous loci. RNAi induction resulted in a decrease of the mRNA coding for NUP158 within 24 hours ([Fig. 2D](#f02){ref-type="fig"}), a reduction in growth rate between 24 and 48 hours ([Fig. 2E](#f02){ref-type="fig"}) and a change in localisation of NUP62--eYFP from predominantly at the edge of the nucleus to a more diffuse nucleoplasmic localisation within 24 hours ([Fig. 2F](#f02){ref-type="fig"}). The redistribution of NUP62--eYFP indicated that nuclear structure was disrupted after induction of NUP158 knockdown. Addition of sinefungin 24 hours after RNAi induction resulted in a reduced formation of NPGs ([Fig. 2F](#f02){ref-type="fig"}). This observation indicates that NPG formation requires nuclear integrity.

Proteins present in NPGs {#s2c}
------------------------

The re-localisation of proteins involved in various mRNA metabolism pathways to NPGs upon inhibition of trans-splicing was further investigated. Targets were expressed as eYFP fusion proteins in cell lines containing transgenes encoding mChFP--DHH1 or SCD6--mChFP or, in one case, PABP2--mChFP. All were expressed after modification of endogenous loci with the exception of LSM5--eYFP which was expressed from a derivative of pDEX377 ([@b39]). The expression of transgenes was verified by western blotting with anti-GFP ([supplementary material Fig. S3](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). Any localisation of the proteins to P-bodies in untreated cells or to NPGs after sinefungin addition was determined ([Fig. 3A](#f03){ref-type="fig"}; [supplementary material Fig. S4](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). The localisation of DHH1 and PABP2 to NPGs was confirmed by immunofluorescence ([Fig. 3A,C](#f03){ref-type="fig"}). For other proteins, it is possible that the eYFP tag has altered the normal localisation and has prevented detection in P-bodies and/or NPGs. The proteins split into three groups: (1) proteins present in both P-bodies and NPGs; (2) proteins present in NPGs but not in P-bodies; and (3) proteins that localised to neither P-bodies nor NPGs.

![**Proteins and RNAs present in NPGs.** (**A**) Summary of localisation of eYFP fusion proteins to P-bodies or NPGs. Designation as present in P-bodies indicates that the protein was readily visualised in P-bodies in untreated cells. However, all the proteins localised to NPGs also localised to P-body-like structures under a range of conditions that increased P-body size, including sinefungin treatment. (**B**) Subcellular localisation of VASA--eYFP and mChFP--DHH1 over a time course of incubation with sinefungin or actinomycin D. (**C**) Fluorescence in situ hybridisation of untreated cells, cells treated with sinefungin for 60 minutes or cells incubated in PBS for 3 hours (starvation). The RNAs detected are shown on the left: mRNA (dT~44~ probe); mRNA and SL RNA (antisense SL RNA exon probe); SL RNA (antisense SL RNA intron probe); and β-tubulin mRNA (antisense β-tubulin mRNA probe).](jcs-125-12-2896-f03){#f03}

Proteins present in both P-bodies and NPGs included SCD6 and DHH1, the translation initiation factor eIF4E1 ([@b16]), as well as three components of the mRNA degradation pathway: the deadenylase CAF1 ([@b79]), the 5′ to 3′ exonuclease XRNA ([@b49]). The *T. brucei* homologue to the NMD factor UPF1 ([@b15]) localised to NPGs, but the expression level of UPF1--eYFP was too low to come to a firm conclusion about whether it was present in P-bodies.

Proteins present in NPGs but not in P-bodies were poly(A) binding protein 2 ([@b73]; [@b32]; [@b12]), an RNA helicase (Tb10.61.2130) that is the closest homologue to VASA in *D. melanogaster* and to GLH1-4 in *C. elegans* ([supplementary material Fig. S5](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)), and eIF4E3 ([@b16]); the latter was only weakly concentrated in NPGs.

Proteins localising to neither P-bodies nor NPGs included all tested proteins with a role in mRNA maturation and export: the splicing factors LSM5 and SmE ([@b56]; [@b51]), the 5′ cap guanylyltransferase-methyltransferase CGM1 ([@b75]; [@b92]), the mRNA export factors XPO1/CRM1 ([@b110]; [@b11]; [@b6]), MEX67 ([@b80]; [@b44]), the putative Ran-binding protein 1 ([@b14]), as well as DRBD3 and DRBD4, RNA-binding proteins related to the polypyrimidine tract binding protein ([@b13]; [@b20]; [@b86]). Proteins that either bind the 5′ cap directly or are part of complexes that bind the cap were tested, but none of the following were present in either P-bodies or NPGs: the nuclear mRNA cap-binding protein CBP20 ([@b50]), the translation initiation factors eIF4E2 ([@b16]) and eIF4G3 ([@b16]), and PABP1, the other poly(A)-binding protein ([@b4]; [@b64]; [@b12]). Three of these, CBP20 ([@b50]), eIF4E2 and eIF4E4 ([@b16]), were expressed at low levels that might have prevented the detection of a small fraction in any granule ([supplementary material Fig. S3](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). These proteins are not listed in [Fig. 3A](#f03){ref-type="fig"}, but are shown in [supplementary material Fig. S4B](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1).

The data suggest that the NPGs are related to P-bodies in their composition. All proteins identified to be normally present in P-bodies also localise to NPGs. Proteins present in NPGs but not normally in P-bodies, PABP2, eIF4E3 and VASA, become visible in P-body derivatives under conditions that result in a dramatic reduction in protein synthesis, such as sinefungin, actinomycin D or carbon source starvation, indicating that they might be minor P-body components under reduced growth conditions. Further evidence for a similarity between P-bodies and NPGs is provided by DHH1 mutant proteins: DHH1 mutants impaired in either RNA-binding (R74A and K76A) ([@b10]) or catalytic activity (E182Q) show impaired localisation to P-bodies ([@b45]) and also a reduced localisation to NPGs ([supplementary material Fig. S6](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). Together, these results suggest a similarity between NPGs and P-bodies.

The addition of sinefungin had a second effect on the subcellular distribution of VASA ([Fig. 3B](#f03){ref-type="fig"}) and DRBD3 ([supplementary material Fig. S4B](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)): both proteins concentrated in the nucleus. This behaviour is consistent with proteins that normally shuttle between the cytoplasm and the nucleus. The relocalisation to the nucleus upon addition of sinefungin could have been caused by a loss of co-export with a mature mRNA or sequestration by binding to the increased pool of incompletely processed mRNAs in the nucleus. To distinguish between these two possibilities, transcription was inhibited using actinomycin D, which prevents both export of newly synthesised mRNA and nuclear accumulation of incompletely processed mRNAs. After addition of actinomycin D, there was no readily observable change in the localisation of VASA or DRBD3 ([Fig. 3](#f03){ref-type="fig"}; [supplementary material Fig. S3](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). Furthermore, addition of actinomycin D 30 minutes before sinefungin prevented nuclear accumulation of VASA. These data suggest that the nuclear accumulation is caused by the presence of incompletely processed mRNAs and not by the absence of fully processed mRNAs.

RNA content of the NPGs {#s2d}
-----------------------

To investigate any RNA content of the NPGs, in-situ hybridisation experiments were performed using the following oligonucleotides: (1) dT~44~ to detect all polyadenylated mRNAs; (2) antisense SL RNA exon to detect mRNAs and SL RNA; (3) antisense SL RNA intron to detect only the SL RNA; and (4) antisense β-tubulin mRNA ([Fig. 3C](#f03){ref-type="fig"}). Sense oligonucleotides were used as controls; all gave significantly weaker signals than the antisense probes (not shown). In untreated cells, mRNA detected by dT~44~ and antisense tubulin probes was distributed throughout the cytoplasm where it was more concentrated than in the nucleus. SL RNA was present at similar concentrations in the cytoplasm and nucleus. On inhibition of trans-splicing, no changes in the localisation of mRNA or SL RNA were observed in the majority of cells. Polyadenylated RNA was detected in the NPGs in the occasional cell but too few (\<1%) to attach significance. DHH1 protein was readily detectable in NPGs by immunofluorescence indicating that the granules survived the in situ hybridisation procedure. The accumulation of mRNAs in starvation stress granules ([@b9]) was used to test the efficacy of the in situ hybridisation procedure: all antisense probes detected the accumulation of mRNAs in starvation stress granules. These experiments suggested that neither mRNAs nor the SL RNA are enriched in NPGs, but it remains possible that any RNA in the granules was not accessible to the probes under the conditions used. The sensitivity of the ISH did not allow us to probe specifically for incompletely spliced mRNAs.

Dependency on translation and transcription {#s2e}
-------------------------------------------

The number and size of P-bodies is often the inverse of the number of polysomes; puromycin releases ribosomes from polysomes and causes an increase in P-bodies, whereas cycloheximide traps ribosomes in polysomes and causes a decrease in P-bodies ([@b82]; [@b1]). This relationship is often interpreted as the physical movement of proteins and mRNAs between polysomes and P-bodies. By contrast, germ granules are not affected by translational inhibitors but, unlike P-bodies, are dependent on active transcription ([@b83]). Cells expressing an eYFP--DHH1 transgene were used to examine any relationship between NPGs, translation and transcription. NPGs were induced by the addition of sinefungin for 30 minutes and the effect of cycloheximide, puromycin or actinomycin D was determined ([Fig. 4A--C](#f04){ref-type="fig"}; [supplementary material Fig. S7A,B](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). Neither cycloheximide nor puromycin dissolved NPGs, whereas both affected P-bodies within 30 minutes: cycloheximide caused visible P-bodies to disappear within 30 minutes and puromycin caused the expected P-body increase ([@b43]). These observations suggest that the protein components localised to NPGs do not exchange with polysomes, or do so at a much slower rate than the exchange between P-bodies and polysomes. Neither cycloheximide nor puromycin had any effect on the oligocistronic tubulin RNAs ([Fig. 4B](#f04){ref-type="fig"}).

![**Actinomycin D, but not cycloheximide, dissolves NPGs and prevents NPG formation.** (**A**) Cells expressing eYFP--DHH1 were incubated with sinefungin for 30 minutes to induce NPG formation and then with other inhibitors as indicated. Images of representative cells are shown, in some cases with an enlargement of the nucleus (Scale bar: 1 µm). (**B**,**C**) Northern blot analysis of incompletely processed tubulin mRNAs from the cells in A. For actinomycin-treated cells, the amount of tubulin dicistrons and β-tubulin mature mRNAs was quantified. Error bars represent s.d. from three independent experiments. (**D**) Cells expressing eYFP--DHH1 were incubated with actinomycin D for 30 minutes and then with sinefungin as indicated. Images of representative cells are shown, in some cases with an enlargement of the nucleus (Scale bar: 1 µm). (**E**) Northern blot analysis of incompletely processed β-tubulin mRNAs from the cells in D. Representative results from three separate experiments are shown.](jcs-125-12-2896-f04){#f04}

By contrast, actinomycin D caused the disappearance of NPGs and a decrease in tubulin oligocistrons within 120 minutes, providing evidence that NPGs are dependent on newly synthesised oligocistronic mRNAs ([Fig. 4A,C](#f04){ref-type="fig"}). This model was reinforced when transcription was inhibited with actinomycin D for 30 minutes before sinefungin, when neither NPGs nor tubulin oligocistrons formed ([Fig. 4D,E](#f04){ref-type="fig"}). Actinomycin D also caused P-bodies to increase in size, as previously reported ([@b58]). The cause of this increase is not understood but might result from a feedback mechanism in which the absence of newly synthesised mRNAs causes a reduction in translation and thus an increase in P-bodies. The experiment also showed that the incompletely processed tubulin mRNAs have a shorter half-life than the mature mRNAs ([Fig. 4C](#f04){ref-type="fig"}), which provides evidence for a selective turnover of aberrant mRNAs.

Depletion of SCD6 causes a reduction in P-bodies but not in NPGs {#s2f}
----------------------------------------------------------------

SCD6 is an RNA-binding protein necessary for the formation of membrane-stress induced P-bodies in *S. cerevisiae* ([@b40]) and its orthologue RAP55 is required for P-body formation in HeLa cells ([@b94]; [@b108]). However, SCD6 is not required for starvation-stress-induced P-body formation in *S. cerevisiae* ([@b95]). RNAi depletion of SCD6 was used to determine whether SCD6 is a core component of trypanosome P-bodies and whether it is required for NPG formation.

The experiments were performed in cell lines expressing mChFP--DHH1 and CAF1--eYFP through modification of endogenous loci (clones 1 and 2) or mChFP--DHH1 alone (clones 3 and 4). Induction of RNAi caused a reduction in SCD6 protein to \<2% after 72 hours ([Fig. 5A](#f05){ref-type="fig"}) and a decrease in the rate of growth after 48 hours ([Fig. 5B](#f05){ref-type="fig"}) but had no effect on the amount of either mChFP--DHH1 or CAF1--eYFP protein over the time course ([Fig. 5A](#f05){ref-type="fig"}). The localisation of both mChFP--DHH1 and CAF1--eYFP to P-bodies was greatly reduced after induction of SCD6 RNAi ([Fig. 5C,D](#f05){ref-type="fig"}; [supplementary material Fig. S8](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). The effect was quantified by determining the percentage of cells with mChFP--DHH1 localising to microscopically visible P-bodies in one plane of focus. This percentage was reduced from \>50% to \<10% within 24 hours of RNAi induction in all four clonal cell lines ([Fig. 5D](#f05){ref-type="fig"}). In addition, the P-bodies still present after RNAi induction appeared smaller. Similarly, the localisation of CAF1--eYFP to P-bodies was reduced from 20% of CAF1--eYFP localising to visible P-bodies in one plane of focus, to 10% after 24 hours of SCD6 RNAi induction ([Fig. 5D](#f05){ref-type="fig"}). Note that CAF1--eYFP was concentrated in P-bodies to a lesser extent than DHH1. The addition of sinefungin resulted in an increase in P-bodies ([Fig. 1A](#f01){ref-type="fig"}); however, after depletion of SCD6 this effect was greatly reduced. Before the induction of SCD6 RNAi, 95% (mChFP--DHH1) or 50% (CAF1--eYFP) of cells contained visible P-bodies in one plane of focus ([Fig. 5D](#f05){ref-type="fig"}). After 24 or 48 hours of SCD6 RNAi, these were reduced to \<30% (DHH1) and \<20% (CAF1). The reduction of localisation of the two proteins to P-bodies is probably a direct consequence of SCD6 knockdown, the effect is present at 24 hours when the growth rate is normal. As a control, growth arrest was induced by RNAi knockdown of either FLA1 ([@b46]) or Polo-like kinase ([@b25]); in both cases, there was no decrease in P-bodies ([supplementary material Fig. S9](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)), indicating that the reduction in P-bodies following SCD6 RNAi is not caused by the reduction in growth or by the RNAi procedure. Thus, *T. brucei* SCD6 is required for correct P-body localisation of at least two P-body markers, consistent with a function as a core-protein of P-bodies.

![**The effect of SCD6 depletion on NPG formation.** SCD6 was depleted in cell lines constitutively expressing either both mCHFP--DHH1 and CAF1--eYFP (clones 1 and 2) or just mChFP--DHH1 (clones 3 and 4). (**A**) Western blot analysis of the parental cell line (Lister 427 pSPR2.1) and a time course of SCD6 RNAi. The blots were probed for DHH1, SCD6 and PFR (loading control). The reduction in SCD6 protein was quantified. One representative blot from four experiments is shown. A non-quantitative western blot was probed for CAF1--eYFP using anti-GFP antibody. (**B**) Growth after induction of SCD6 RNAi. One representative growth analysis from four experiments is shown. (**C**) The effect of incubation with sinefungin on cells before and after induction of SCD6 RNAi. Images of typical cells before (no TET) and 24 hours after RNAi induction SCD6 RNAi (24 h TET) are shown. (**D**) Quantification of the sinefungin-induced relocalisation of mChFP--DHH1 and CAF1--eYFP before and after induction of SCD6 RNAi. The percentage of cells with mChFP--DHH1 or CAF1-eYFP localised to cytoplasmic granules other than NPGs in one plane of focus was quantified from \>100 microscopy images.](jcs-125-12-2896-f05){#f05}

By contrast, the localisation of mChFP--DHH1 and CAF1--eYFP to NPGs after addition of sinefungin was unaffected by SCD6 knockdown ([Fig. 5C](#f05){ref-type="fig"}; [supplementary material Fig. S8](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1)). A minor change in the abundance of the NPGs cannot be excluded, because the dissociation of the cytoplasmic P-bodies slightly increases the cytoplasmic fluorescence, making a direct comparison of microscopic images difficult. However, addition of sinefungin caused the appearance of clearly visible NPGs in every cell at 24, 48 and 72 hours after induction of SCD6 RNAi. These data indicate that SCD6 is required for P-body formation, but not for the formation of the NPGs. The independence of NPG formation from SCD6 prevented a readily accessible investigation of the effect of perturbing NPG formation on mRNAs.

Incompletely processed mRNAs are present in the cytoplasm {#s2g}
---------------------------------------------------------

Inhibition of trans-splicing caused the formation of NPGs in the cytoplasm and accumulation of partially spliced mRNAs. To determine whether the incompletely processed mRNAs were confined to the nucleus, both control and sinefungin-treated cells were fractionated and protein and RNA prepared. Northern blots were probed for expression of tubulin and HSP83, which is also transcribed from tandemly arranged genes and therefore suitable for the detection of incompletely spliced mRNAs ([@b65]), as well as for control RNAs: tRNA^leu^ as a cytoplasmic marker, U3 snRNA as a nuclear marker. Western blots were probed for histone H3 as a nuclear marker, PFR (a marker of the cytoskeleton which co-fractionates with nuclei in the procedure used) and for BiP (an ER protein that was used as a cytoplasmic marker after detergent lysis) ([Fig. 6](#f06){ref-type="fig"}). The majority of the U3 snRNA was in the nuclear fraction, suggesting little contamination of the cytoplasmic fraction with nuclear RNAs. All the tRNA^leu^ was present in the cytoplasmic fraction indicating no contamination of the nuclear fraction with cytoplasm. More than half of dicistronic mRNA encoding β-tubulin and HSP83 were found in the cytoplasmic fraction. The β-tubulin dicistrons were quantified using phosphorimager analysis and the cytoplasmic fraction/nuclear fraction (C/N) ratio was 1.33, the C/N ratio for U3 snRNA was 0.30. These measurements indicate that the dicistrons present in the cytoplasmic fraction do not arise from nuclear contamination. Very low levels of tubulin dicistrons were detectable in the cytoplasmic fraction even in the absence of sinefungin (asterisk in [Fig. 6](#f06){ref-type="fig"}), suggesting that low levels of incompletely spliced mRNAs in the cytoplasm occur normally. These data provide strong evidence for the presence of incompletely processed mRNAs in the cytoplasm. The larger incompletely processed mRNAs, equivalent to tetracistronic tubulin and larger, showed a greater retention in the nucleus. It is possible that a nuclear retention factor that binds the intron sequences had become limiting and the larger incompletely processed mRNAs with more introns are more likely to be retained. Another possible explanation is that the larger RNAs are retained in the nucleus simply because of their larger size.

![**Partially processed mRNAs are present in the cytoplasm.** RNA and protein from total, cytoplasmic (SN) and nuclear (pellet) fractions of a subcellular fractionation were analysed by Northern blotting for tubulin and HSP83 to detect partially processed mRNAs and for tRNA^leu^, U3 snRNA to control for fractionation. The asterisk indicates the dicistronic tubulin mRNA in the cytoplasmic fraction, visible in the absence of sinefungin. In parallel, protein samples were analysed by western blotting for histone H3, BiP and PFR. The same cell equivalents were loaded in each track.](jcs-125-12-2896-f06){#f06}

Inhibition of splicing in HeLa cells does not cause the formation of NPGs {#s2h}
-------------------------------------------------------------------------

Trypanosomes represent a branch of eukaryotes that are as divergent from metazoa as any eukaryote ([@b105]). To investigate whether NPGs are a general phenomenon, the effect of inhibition of splicing in HeLa cells was investigated. Splicing was inhibited by the addition of spliceostatin A, previously shown to inhibit splicing in HeLa cells by binding to the splicing factor SF3B ([@b36]; [@b52]). The inhibition of splicing was monitored by the reorganisation of splicing factors within the nucleus from 20--50 irregularly shaped foci into a smaller number of larger foci ([@b69]; [@b93]; [@b36]). Addition of spliceostatin A to HeLa cells caused re-localisation of SC35 into larger foci in the majority of the cells within 2 hours ([Fig. 7A](#f07){ref-type="fig"}), as previously described ([@b36]). However, rck (p54), the orthologue of DHH1, did not localise to granules at the nuclear periphery up to the endpoint of 5 hours of incubation with spliceostatin A ([Fig. 7A](#f07){ref-type="fig"}). A second method to inhibit splicing was used: a morpholino oligonucleotide designed to pair with U2 snRNA, equivalent in sequence to the one used above with trypanosomes, was introduced into HeLa cells by electroporation ([@b59]). Again, SC35 relocalised to a smaller number of enlarged foci within the nucleus indicating successful inhibition of splicing, but no rck (p54) granules around the nuclear periphery were observed 24 hours after transfection ([Fig. 7B](#f07){ref-type="fig"}). The results of these experiments indicate that it is unlikely that NPGs form in HeLa cells in response to inhibition of splicing, but it remains possible that inhibition was incomplete. The induction of NPGs in trypanosomes but not HeLa cells could result from a trivial difference in the effectiveness of inhibition: spliceostatin A only partially inhibits splicing of a reporter in HeLa cells, even at very high concentrations ([@b36]). However, the U2 morpholinos target the same reaction and might be expected to have a similar effect. There could also be a mechanistic difference. It is worth noting that all trypanosome mRNAs are trans-spliced but ∼6% of human genes have a single exon ([@b106]) and the export of these would be expected to continue when splicing was inhibited, perhaps this is enough to stop visible NPGs forming.

![**Inhibition of splicing in HeLa cells does not result in NPG formation.** Inhibition of splicing in HeLa cells by Spliceostatin A (100 ng/ml for 5 hours using a 100 µg/ml stock in methanol) (**A**) or a morpholino antisense to the U2 snRNA (**B**). Methanol (0.1%) or a morpholino sense to *T. brucei* β-tubulin served as controls. Rck (p54) and SC35 proteins were detected by immunofluorescence, using anti-rck/p54 (Bethyl Laboratories) or anti-SC35 (Sigma) antibodies.](jcs-125-12-2896-f07){#f07}

Discussion {#s3}
==========

Trans-splicing is an essential step in mRNA processing in many eukaryotes; in trypanosomes, all mRNAs require trans-splicing, whereas only 2 of the \>5000 genes contain a cis-intron. The trans-splicing reaction adds the capped 39 nucleotide exon from the SL RNA to the 5′ end of all nuclear encoded mRNAs ([@b77]). The trypanosome 5′ cap is particularly ornate, with 5 to 7 methylations on the first 4 nucleotides of the SL-RNA-derived exon ([@b3]), and methylation of the SL RNA is required before trans-splicing ([@b100]). The extensive methylation of SL RNA probably causes the extreme sensitivity of trans-splicing to sinefungin, an S-adenosyl methionine analogue. The efficiency of trans-splicing varies with the sequence around the splice site ([@b84]), yet only very low levels of incompletely spliced mRNAs are detected in normally growing cells. This infers that there is a quality control mechanism that normally recognises and degrades incompletely spliced mRNAs. Further evidence for such a pathway comes from experiments that investigated the fate of accumulated incompletely processed β-tubulin mRNAs produced during heat shock; on recovery from heat shock, these were degraded rather than processed to mature mRNAs ([@b66]), and in the experiments presented here, sinefungin-induced tubulin dicistrons decayed more rapidly than mature tubulin mRNA ([Fig. 4](#f04){ref-type="fig"}).

Here, the cellular response to increased partially processed mRNAs has been investigated. The main findings are: (1) inhibition of trans-splicing by either sinefungin or an U2 snRNA antisense morpholino oligonucleotide causes the formation of nuclear periphery granules (NPGs) external to the nucleus. NPG formation is dependent on the integrity of the nucleus. (2) NPGs contain a set of proteins involved in regulating mRNA fate. (3) The presence of NPGs is dependent on newly synthesised but incompletely processed mRNAs, because they do not form when transcription is inhibited and, once formed, dissociate when transcription is inhibited. (4) Part of the incompletely spliced mRNAs are present in cytoplasmic fractions. (5) NPG formation does not require the P-body core protein SCD6.

NPGs have not been reported in response to heat shock, a stress that causes the accumulation of partially processed mRNAs ([@b43]) and the question arises as to whether the NPGs represent a true compartment for mRNA metabolism. However, there is an important difference between heat shock and the inhibition of trans-splicing by sinefungin. The action of sinefungin is rapid and completely blocks mRNA maturation; whereas during stress, gene expression continues, although at a reduced rate, and thus inhibition of trans-splicing is not complete ([@b43]). The evidence points towards the formation of visible NPGs requiring a fast and (almost) complete inhibition of trans-splicing, currently only achieved with sinefungin or the morpholino antisense to the U2 snRNA. It is likely that NPGs represent structures that are otherwise present in a smaller or very transient form.

Incomplete trans-splicing results in mRNAs that are capped and polyadenylated, contain more than one open reading frame and one or more introns. Export of such mRNAs into the cytoplasm is potentially deleterious because most dicistrons will contain mixed regulatory elements. The observation that partially processed β-tubulin mRNAs are more concentrated in the nucleus \[∼50% is present in the cytoplasm but the volume is ∼eightfold larger than the nucleus ([@b24])\], indicates that some retention system must be present. The finding that incompletely processed mRNA is readily detectable in the cytoplasm, even when trans-splicing is not inhibited, as well as the previously reported cytoplasmic location of a dicistronic mRNA ([@b34]) argues that any quality control system may not be perfect. In other organisms, incompletely cis-spliced mRNAs encode aberrant, potentially harmful proteins. In yeast, control systems at the nuclear pore prevent the majority of incompletely processed mRNAs from entering the cytoplasm. Nuclear retention requires the assembly of the spliceosome on the pre-mRNA ([@b48]; [@b74]; [@b76]), suggesting that the presence of the spliceosome prevents pre-mRNA export. The control system is not perfect, and small amounts of unspliced mRNAs do enter the cytoplasm; this was shown by measuring the activity of gene products arising from the translation of unspliced reporter mRNAs containing in-frame introns ([@b109]; [@b48]). Cytoplasmic incompletely cis-spliced mRNAs are targets for nonsense-mediated decay (NMD) ([@b29]; [@b76]; [@b30]; [@b35]; [@b78]; [@b37]), although there might be exceptions ([@b36]). Several yeast genes involved in retention of immature mRNAs have been identified including the perinuclear pore protein Mlp1 ([@b22]) and the nuclear components Pml1 ([@b17]) and Pml39 ([@b70]). Orthologues of Pml1 and Pml39 are not readily identified in the trypanosome genome and a putative orthologue of Mlp1 has been identified based on location and domain architecture rather than sequence ([@b14]). However, the evolutionary distance between yeast and trypanosomes is such that the failure to identify clear orthologues does not indicate the absence of a conserved pathway.

NPGs have an overlapping protein composition with P-bodies, but have more similarities with germ granules present in metazoan adult gonads; they share: (1) a localisation at the nuclear periphery ([@b18]; [@b53]; [@b54]; [@b88]; [@b89]; [@b28]), (2) the presence of VASA ([@b27]), (3) stability in the presence of cycloheximide ([@b83]), (4) a dependence on transcription ([@b83]) and (5) a requirement for integrity of the nucleus ([@b104]). At this stage, it has not been possible to determine whether NPGs are associated with clusters of nuclear pore complexes enriched for mRNA export factors, a feature of some germ granules. A further clear difference between NPGs and P-bodies is the independence of NPG formation from SCD6, a core protein in P-bodies. Perinuclear germ granules mark the site of mRNA exit from the nucleus and have been suggested to act as sorting compartments to determine the further fate of the mRNAs ([@b83]); they might represent a cytoplasmic extension of nuclear pores ([@b102]). It is tempting to speculate that trypanosome NPGs might fulfil a similar function.

On addition of sinefungin, the pool of fully methylated SL RNA decreases over a few minutes and at a threshold concentration splicing stops with an accumulation of many times the normal concentration of partially processed mRNAs and the formation of NPGs. Inhibition of transcription does not result in NPG formation and inhibition of transcription once NPGs have formed causes them to disappear. Thus, it is the increase in newly synthesised but incompletely processed mRNAs that results in the formation of NPGs. The function of NPGs remains uncertain, but it can be speculated that NPGs are an enlarged form of a normal regulatory compartment that functions not only in quality control but also to label newly synthesised mRNAs for one of their possible fates elsewhere in the cytoplasm: translation, storage or degradation. Furthermore, the similarities between NPGs and the germ granules present in metazoa suggest that the compartment was present before the divergence of eukaryotes and so represents a basic step in mRNA metabolism.

Materials and Methods {#s4}
=====================

Trypanosomes {#s4a}
------------

*Trypanosoma brucei* Lister 427 procyclic cells (a kind gift from Keith Gull; Sir William Dunn School of Pathology, University of Oxford, UK) were used for most experiments. RNAi experiments were done in either Lister 427 pSPR2.1 cells ([@b90]) (SCD6, SmE, NUP158) or PTT (Philippe Bastin, Institute Pasteur, Paris, France) (FlaI, Polo-like-kinase); over-expression in either Lister 427 SIMP (Bill Wickstead, Sir William Dunn School of Pathology, Oxford, UK) (Lsm5) or PTT (Philippe Bastin, Institute Pasteur, Paris, France) (DHH1 and dhh1 mutants) or Lister 427 pSPR2.1 cells ([@b90]) (SCD6). Transgenic trypanosomes were generated using standard procedures ([@b61]). All experiments were performed with logarithmically growing trypanosomes at a cell density of less than 1×10^7^ cells/ml.

Plasmids and cloning {#s4b}
--------------------

Details of all plasmids are described in [supplementary material Table S1](http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.099275/-/DC1). RNAi of Polo-like kinase was carried out with a previously described plasmid ([@b25]).

Inhibitor treatments {#s4c}
--------------------

Puromycin and cycloheximide were used at 50 µg/ml, sinefungin at 2 µg/ml; all concentrated stocks were dissolved in SDM79 without serum and haemin. Actinomycin D was used at 10 µg/ml from a 100× stock dissolved in ethanol.

Trypanosome morpholino experiments {#s4d}
----------------------------------

Morpholino oligos were synthesised by GeneTool: 5′-TGATAAGAACAGTTTAATAACTTGA-3′ (U2 snRNA, Tb927.2.5680); 5′-GAAAATAGTTCAAACGAATTATGCG-3′ (control, β-tubulin sense).

1.5×10^7^ cells were washed once in cytomix (10 mM K~2~HPO~4~/KH~2~PO~4,~ pH 7.6, 2 mM EGTA, 120 mM KCl, 150 µM CaCl~2~, 25 mM HEPES, 5 mM MgCl~2~, 0.5% glucose, 1 mM hypoxanthine, 100 µg/ml BSA), resuspended in 100 µl cytomix + 16 µl morpholino (at 500 µM) and electroporated using the Amaxa Nucleofector electroporator (programme: X-001). Cells were analysed 2 hours following electroporation by fluorescence microscopy or Northern blot.

RNA work {#s4e}
--------

Quantitative Northern blots and sucrose density gradients were performed as described ([@b43]). For better detection of β-tubulin mRNA precursors, an on-column DNAse treatment was performed during RNA isolation (Qiagen). To control for loading, blots were reprobed for rRNA, in some cases non-radioactively by using an oligo antisense to the 18S rRNA (5′-CCTTCGCTGTAGTTCGTCTTGGTGCGGTCTAAGAATTTC-3′) coupled to IRDye800. Hybridisation of blots probed with oligos was performed at 42°C and the blot was washed at room temperature in 4× SSC, 0.1%SDS and RNA was detected and quantified using the Odyssey system (Licor).

Nucleus cytoplasm separation {#s4f}
----------------------------

Subcellular fractionation of RNA was essentially done as described previously ([@b34]). Preparation of RNA from the fractions was carried out using hot phenol extraction, followed by phenol--chloroform extraction, ethanol precipitation and treatment with RNase-free DNase (Qiagen).

Microscopic imaging and detergent lysis {#s4g}
---------------------------------------

Microscopic imaging of cells was performed as described ([@b43]). For deconvolution of a *Z*-stack image, the theoretical point spread function and the iterative algorithm of the AxioVision software was used (default settings). For detergent lysis, 1×10^7^ cells were resuspended in 285 µl SDM79 without serum and haemin, lysed by the addition of 15 µl 10% n-octylglycoside (final concentration 0.5%), Hoechst 33342 DNA stain was added and images were taken immediately.

Immunofluorescence and fluorescent in situ hybridisation for RNA detection {#s4h}
--------------------------------------------------------------------------

2×10^7^ cells were washed once in SDM79 without serum and haemin, resuspended in 5 ml SDM79 without serum and haemin and fixed for 15 minutes by the addition of 5 ml 8% paraformaldehyde (dissolved in PBS) whilst rotating. 5 ml fixed cells were washed once in 45 ml PBS, resuspended in 2 ml PBS and allowed to settle on slides. Slides were washed in 25 mM NH~4~Cl for 10 minutes. Cells were permeabilised and blocked for 1 hour in blocking solution (taken from fluorescent antibody enhancer set for DIG detection, Roche) containing 0.5% saponin. Prehybridisation was done for two hours in hybridisation solution (1× blocking solution, 5× Denhardt, 4× SSC, 35% deionised formamide, 0.5 mg/ml tRNA). Hybridisation was performed overnight in a humid chamber at room temperature in hybridisation solution containing 0.5 ng/µl (poly A, spliced leader) or 5 ng/µl (SL RNA, tubulin) biotinylated oligo. Slides were washed twice in 4× SSC, 35% formamide, once in 4× SSC, once in 2× SSC and once in PBS. Detection was by blocking for 30 minutes in blocking solution, followed by 60 minutes incubation with Alexa-Fluor-568--streptavidin (1∶200) and DHH1 antiserum (1∶5000) in blocking solution, followed by four washing steps in PBS, followed by 60 minutes incubation with Alexa Fluor 488 goat anti-rabbit (1∶200) antibody in blocking solution, followed by four washing steps in PBS. Slides were mounted in FluorSave Reagent (Calbiochem), containing Hoechst 33342 DNA stain at 5 µg/ml. Oligo sequences were: 5′ Biotin (T)~44~ 3′ Biotin (poly A), 5′-Biotin-CAATATAGTACAGAAACTGTTCTAATAATAGCGTT-3′-Biotin (spliced leader); 5′-Biotin-GGTCATCCGACCCCACCTTCCAGATTCCCGCAGTA-3′-Biotin (SL RNA); 5′-Biotin-CAGACGCTGTCAGGTAGCGGCCGTGACGAGGATCTGCAGC-3′ (β-tubulin).

Control oligos were antisense to the oligos above, used in the same concentrations and cells were imaged at the same exposure times. Immunofluorescence experiments were performed in an identical manner, but without the prehybridisation and hybridisation steps.

Western blots {#s4i}
-------------

Western blots were performed using standard protocols. Detection was either by ECL or using the Odyssey Infrared Imaging System (LI-COR). For quantification, the Odyssey software was used (background method: the average of a three pixel width line at the top and bottom of each band was subtracted from each pixel). Unequal loading was corrected by reprobing the blots for BiP or PFR (L13D6).

HeLa cell experiments {#s4j}
---------------------

HeLa cells were routinely maintained in DMEM. For immunofluorescence, cells were grown on 13 mm glass coverslips for 24 hours. Splicing was inhibited by the addition of spliceostatin A to the cells at 100 ng/ml for up to 5 hours using a 100 µg/ml stock in methanol for a maximum of 5 hours (the same volume of methanol served as control). Cells were rinsed with PBS, fixed in 4% paraformaldehyde in PBS for 20 minutes, rinsed twice in PBS, permeabilised in 0.5% TritonX-100 in PBS for 4.5 minutes, rinsed twice in PBS, incubated with primary antibodies (rabbit anti-rck/p54 1∶1000 and mouse anti-SC35 1∶500 in PBS with 5% BSA) for 1 hour, washed twice in PBS, incubated with secondary antibody conjugated to Rhodamine (rabbit) or dy488 (mouse) (1∶1000 in PBS, 5% BSA) for 1 hour, washed twice in PBS. After rinsing three times with PBS, cells were stained with DAPI (1.25 µg/ml) for 10 seconds. Coverslips were mounted in Citifluor (Citifluor Labs, Birmingham, UK).

Splicing was also inhibited by the electroporation of a morpholino (TGATAAGAACAGATACTACACTTGA, antisense to U2 snRNA, 10 µl of 1 mM stock) into 2×10^5^ cells of trypsinised HeLa cells resuspended in 100 µl supplemented nucleofector solution using the Amaxa Nucleofector (programme I-013). The control morpholino used was 5′-GAAAATAGTTCAAACGAATTATGCG-3′ (β-tubulin sense). After electroporation, cells were resuspended in 500 µl pre-warmed medium and transferred into a 24-well plate containing a 13 mm glass coverslip. Fixation and immunofluorescence were performed 24 hours after electroporation as above.
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